89 related articles for article (PubMed ID: 7954377)
1. Squamous cell cervical lesions in women with and without AIDS. Biochemical risk factors, prevention, and policy.
Lovejoy NC; Anastasi JK
Cancer Nurs; 1994 Aug; 17(4):294-307. PubMed ID: 7954377
[TBL] [Abstract][Full Text] [Related]
2. Limited impact of immunosuppression and HAART on the incidence of cervical squamous intraepithelial lesions in HIV-positive women.
Heard I; Potard V; Costagliola D
Antivir Ther; 2006; 11(8):1091-6. PubMed ID: 17302379
[TBL] [Abstract][Full Text] [Related]
3. Cervical neoplasia in women with HIV infection.
Maiman M
Oncology (Williston Park); 1994 Aug; 8(8):83-9; discussion 89, 93-4. PubMed ID: 7947005
[TBL] [Abstract][Full Text] [Related]
4. Squamous intraepithelial lesions of the cervix, invasive cervical carcinoma, and immunosuppression induced by human immunodeficiency virus in Africa. Dyscer-CI Group.
La Ruche G; Ramon R; Mensah-Ado I; Bergeron C; Diomandé M; Sylla-Koko F; Ehouman A; Touré-Coulibaly K; Welffens-Ekra C; Dabis F
Cancer; 1998 Jun; 82(12):2401-8. PubMed ID: 9635533
[TBL] [Abstract][Full Text] [Related]
5. Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections.
Hawes SE; Critchlow CW; Faye Niang MA; Diouf MB; Diop A; Touré P; Aziz Kasse A; Dembele B; Salif Sow P; Coll-Seck AM; Kuypers JM; Kiviat NB
J Infect Dis; 2003 Aug; 188(4):555-63. PubMed ID: 12898443
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of cervical squamous intraepithelial lesions among HIV-positive women in Enugu, South-eastern Nigeria.
Dim CC; Ezegwui HU; Ikeme AC; Nwagha UI; Onyedum CC
J Obstet Gynaecol; 2011 Nov; 31(8):759-62. PubMed ID: 22085071
[TBL] [Abstract][Full Text] [Related]
7. Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women.
Ahdieh-Grant L; Li R; Levine AM; Massad LS; Strickler HD; Minkoff H; Moxley M; Palefsky J; Sacks H; Burk RD; Gange SJ
J Natl Cancer Inst; 2004 Jul; 96(14):1070-6. PubMed ID: 15265968
[TBL] [Abstract][Full Text] [Related]
8. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
9. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women.
Strickler HD; Burk RD; Fazzari M; Anastos K; Minkoff H; Massad LS; Hall C; Bacon M; Levine AM; Watts DH; Silverberg MJ; Xue X; Schlecht NF; Melnick S; Palefsky JM
J Natl Cancer Inst; 2005 Apr; 97(8):577-86. PubMed ID: 15840880
[TBL] [Abstract][Full Text] [Related]
10. Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2.
Hawes SE; Critchlow CW; Sow PS; Touré P; N'Doye I; Diop A; Kuypers JM; Kasse AA; Kiviat NB
J Natl Cancer Inst; 2006 Jan; 98(2):100-9. PubMed ID: 16418512
[TBL] [Abstract][Full Text] [Related]
11. Prevention of cervical cancer.
Denny L
Reprod Health Matters; 2008 Nov; 16(32):18-31. PubMed ID: 19027619
[TBL] [Abstract][Full Text] [Related]
12. Cervical carcinoma in Nigeria--a need for early detection.
Edozien LC; Adewole IF
Afr J Med Med Sci; 1993 Dec; 22(4):87-92. PubMed ID: 7839937
[No Abstract] [Full Text] [Related]
13. Effect of HIV infection on atypical squamous cells of undetermined significance.
Duerr A; Paramsothy P; Jamieson DJ; Heilig CM; Klein RS; Cu-Uvin S; Schuman P; Anderson JR;
Clin Infect Dis; 2006 Mar; 42(6):855-61. PubMed ID: 16477565
[TBL] [Abstract][Full Text] [Related]
14. One world, one hope...one gender?
Gorna R
J Int Assoc Physicians AIDS Care; 1996 Oct; 2(10):28-30, 32-4. PubMed ID: 11363910
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
Schuman P; Ohmit SE; Klein RS; Duerr A; Cu-Uvin S; Jamieson DJ; Anderson J; Shah KV;
J Infect Dis; 2003 Jul; 188(1):128-36. PubMed ID: 12825181
[TBL] [Abstract][Full Text] [Related]
16. Screening HIV-infected women for cervical cancer in Thailand: findings from a demonstration project.
Sirivongrangson P; Bollen LJ; Chaovavanich A; Suksripanich O; Virapat P; Tunthanathip P; Ausavapipit J; Lokpichat S; Siangphoe U; Jirarojwat N; Pobkeeree V; Supawitkul S; Tappero JW; Levine WC
Sex Transm Dis; 2007 Feb; 34(2):104-7. PubMed ID: 16755274
[TBL] [Abstract][Full Text] [Related]
17. HIV infection among Uganda women with cervical cancer: a retrospective study.
Sekirime WK; Gray R
Gynecol Obstet Invest; 2007; 63(4):222-8. PubMed ID: 17191009
[TBL] [Abstract][Full Text] [Related]
18. Cervical dyskaryosis among women with and without HIV: prevalence and risk factors.
Mbizvo EM; Msuya SE; Stray-Pedersen B; Chirenje MZ; Hussain A
Int J STD AIDS; 2005 Dec; 16(12):789-93. PubMed ID: 16336759
[TBL] [Abstract][Full Text] [Related]
19. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.
Castellsagué X; Díaz M; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Peeling RW; Ashley R; Smith JS; Snijders PJ; Meijer CJ; Bosch FX;
J Natl Cancer Inst; 2006 Mar; 98(5):303-15. PubMed ID: 16507827
[TBL] [Abstract][Full Text] [Related]
20. Developing an effective HIV/AIDS response for women and girls in the U.S. Virgin Islands.
Downer GA; Callwood GB
Womens Health Issues; 2011 Nov; 21(6 Suppl):S283-6. PubMed ID: 21782464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
